Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLECTORGO satisfaction, effectiveness, and tolerability study in acute musculoskeletal pain
2018-004886-15Phase 4Completed
- Sponsor
- IBSA Group
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of diclofenac in Musculoskeletal pain, sponsored by IBSA Group. Primary endpoint: Overall treatment satisfaction at 72 ± 7 hours. Started Jan 2021; status: completed.
02
Drugs
diclofenac
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on 2018-004886-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004886-15.